Soumen Bhattacharyya: Clinical Implications and Risks in Metformin-Induced Vitamin B12 Deficiency
Soumen Bhattacharyya, College Teacher in the Department of Physiology at RBC College for Women, shared a post on LinkedIn:
“Metformin, Vitamin B12 Deficiency and Homocysteine: An Overlooked Clinical Link.
Metformin remains the cornerstone therapy for due to its efficacy, safety, and cardiovascular benefits.
However, an important long-term adverse effect often goes under-recognized: vitamin B12 deficiency and its metabolic consequences.
What’s the mechanism?
Metformin interferes with the calcium-dependent absorption of the intrinsic factor–vitamin B12 complex in the terminal ileum.
Additional contributing factors include altered gut motility and possible bacterial overgrowth.
Over time, this leads to reduced serum B12 levels.
Why does this matter?
Vitamin B12 plays a critical role in the conversion of homocysteine to methionine.
When B12 levels fall:
- Homocysteine accumulates
- Leads to a state of hyperhomocysteinemia
Clinical implications:
- Peripheral neuropathy (may mimic or worsen diabetic neuropathy)
- Megaloblastic anemia
- Increased cardiovascular risk associated with elevated homocysteine
What does the evidence say?
- Long-term metformin therapy is significantly associated with reduced B12 levels (de Jager et al., 2010)
- Reviews highlight impaired absorption as the primary mechanism (Niafar et al., 2021)
- Systematic analyses show increased homocysteine, particularly without vitamin supplementation (Aroda et al., 2016)
Clinical takeaway:
- Consider periodic monitoring of vitamin B12 in long-term metformin users
- Supplementation (oral or parenteral) when deficiency is detected
- Evaluate unexplained neuropathy carefully—don’t attribute everything to diabetes
Key References:
- de Jager J et al. Long-term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency. BMJ, 2010.
- Niafar M et al. Long-term metformin therapy and vitamin B12 deficiency. (Review, PMC8311483)
- Aroda VR et al. Metformin and vitamin B12 deficiency: a systematic review.
A simple intervention—monitoring B12—can prevent significant morbidity in millions of patients on metformin.”

Stay updated with Hemostasis Today.
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology